David R Friend

Summary

Affiliation: Eastern Virginia Medical School
Country: USA

Publications

  1. doi Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned
    David R Friend
    CONRAD, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Arlington, VA 22209, USA Electronic address
    Antiviral Res 99:391-400. 2013
  2. ncbi Multipurpose prevention technologies: products in development
    David R Friend
    CONRAD Program, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, 1911 N Fort Myer Drive, Suite 900, Arlington, VA 22209, United States Electronic address
    Antiviral Res 100:S39-47. 2013
  3. doi Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission
    David R Friend
    Eastern Virginia Medical School, CONRAD, Department of Obstetrics and Gynecology, 1911 North Fort Myer Drive, Suite 900, Arlington, VA 22209, USA
    Expert Opin Drug Deliv 9:417-27. 2012
  4. doi Pharmaceutical development of microbicide drug products
    David R Friend
    CONRAD, Arlington, Virginia 22209, USA
    Pharm Dev Technol 15:562-81. 2010
  5. doi Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies
    David R Friend
    CONRAD, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, 1911 North Fort Myer Drive, Arlington, VA 22209, USA
    Antiviral Res 88:S47-54. 2010
  6. doi Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits
    Meredith R Clark
    CONRAD, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Arlington, Virginia, USA
    AIDS Res Hum Retroviruses 28:1458-66. 2012
  7. doi A hot-melt extruded intravaginal ring for the sustained delivery of the antiretroviral microbicide UC781
    Meredith R Clark
    CONRAD, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Arlington, Virginia 22209, USA
    J Pharm Sci 101:576-87. 2012

Collaborators

  • Patrick F Kiser
  • Meredith R Clark
  • Hoda Elgendy
  • R Tyler McCabe
  • Todd J Johnson
  • Justin T Clark
  • Anthony Tuitupou

Detail Information

Publications7

  1. doi Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned
    David R Friend
    CONRAD, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Arlington, VA 22209, USA Electronic address
    Antiviral Res 99:391-400. 2013
    ..It is now clear that product adherence could be the greatest challenge to demonstrating topical (and to a similar extent oral) PrEP. Novel dosage forms should play a role in creating products that women will use correctly...
  2. ncbi Multipurpose prevention technologies: products in development
    David R Friend
    CONRAD Program, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, 1911 N Fort Myer Drive, Suite 900, Arlington, VA 22209, United States Electronic address
    Antiviral Res 100:S39-47. 2013
    ..It forms part of a special supplement to Antiviral Research...
  3. doi Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission
    David R Friend
    Eastern Virginia Medical School, CONRAD, Department of Obstetrics and Gynecology, 1911 North Fort Myer Drive, Suite 900, Arlington, VA 22209, USA
    Expert Opin Drug Deliv 9:417-27. 2012
    ..The development of multiple indication (multipurpose) prevention technologies (MIPTs) is driven by overlapping relationships in the area of female reproductive health...
  4. doi Pharmaceutical development of microbicide drug products
    David R Friend
    CONRAD, Arlington, Virginia 22209, USA
    Pharm Dev Technol 15:562-81. 2010
    ..Dual protection systems are also under development. These systems include formulations capable of preventing HIV infection along with a second drug capable of preventing conception or other viral infections such as HSV...
  5. doi Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies
    David R Friend
    CONRAD, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, 1911 North Fort Myer Drive, Arlington, VA 22209, USA
    Antiviral Res 88:S47-54. 2010
    ..This article forms part of a special supplement on a presentation covering DPTs, based on the symposium "Trends in Microbicide Formulations", held on 25 and 26 January 2010, Arlington, VA...
  6. doi Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits
    Meredith R Clark
    CONRAD, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Arlington, Virginia, USA
    AIDS Res Hum Retroviruses 28:1458-66. 2012
    ..These data indicate that the reduced-glycerin TFV 1% gel may be a suitable alternative to TFV 1% gel...
  7. doi A hot-melt extruded intravaginal ring for the sustained delivery of the antiretroviral microbicide UC781
    Meredith R Clark
    CONRAD, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Arlington, Virginia 22209, USA
    J Pharm Sci 101:576-87. 2012
    ..Overall, UC781 was formulated in a stable PU IVR and provided controlled release of UC781 both in vitro and in vivo...